The University of Iowa
Iowa City, Iowa, 52242, United States
Location status: Recruiting
Location contact
John Keller
CONTACT
Paolo Goffredo, MD
PRINCIPAL_INVESTIGATOR
Thomas Granchi, MD
SUB_INVESTIGATOR
NCT Number: NCT03476941
Intra-abdominal abscesses are pus-filled pouches in the abdominal cavity. Current standard of care includes drain placement in the abscess cavity to reach source control as well as administration of systemic antibiotics. It is common practice to flush the drain on a daily basis to ensure patency. This study aims to analyze the clinical impact of a higher local concentration of antibiotics (rather than normal saline) provided through drain irrigation with an antimicrobial agent (Gentamicin and/or Clindamycin) compare to normal saline.
Interested in participating?
Request Info18 year–80 year
All sexes
Interventional
Phase 2
Iowa City, Iowa, 52242, United States
Location status: Recruiting
John Keller
CONTACT
Paolo Goffredo, MD
PRINCIPAL_INVESTIGATOR
Thomas Granchi, MD
SUB_INVESTIGATOR
People with an abdominal abscess who undergo drain placement will have those drains irrigated twice/day with either normal saline (placebo group) or with the above antibiotic solution for a total of 7 days or less if the drain were to be removed earlier. Outcomes of interest are duration of systemic antibiotics, and WBC and temperature curve.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Irrigate surgical drain with total amount of 5 mg in 10 ml volume twice/day for 7 days or until drain removal if less than 7 days of therapy.
Irrigate surgical drain with total amount of 12 mg in 10 ml volume once daily for 7 days or until drain removal if less than 7 days of therapy.
The placebo group will receive drain irrigation twice/day
Time frame: From initiation of systemic treatment until 1 month follow up
Total duration of systemic antibiotics will be recorded from the start of the treatment until discontinuation by primary care team. This will be measured as days from diagnosis to when the antibiotic treatment gets interrupted. Duration of systemic antibiotics will be our primary outcome measurement. Duration of systemic antibiotics will be monitored as an indication of the effectiveness of the proposed intervention.
Time frame: From initiation of systemic treatment until 1 month follow up
White blood count level from the blood draw will be measured starting from the admission until discharge or discontinuation by primary care team. During follow up, if white blood count will be measured, will record up to 1 month follow up. The white blood count will be measured once daily and as needed depending on clinical changes. We will plan to trend WBC as another indication of decreasing systemic inflammation.
Time frame: From initiation of systemic treatment until 1 month follow up
Temperature will be measured every 8 hours starting from admission and until patient discharge. And also temperature will be measured during each follow up clinic visit. Change in temperature is monitored as an indication of decrease systemic inflammation.
Time frame: From patient initial hospitalization up to 1 month follow up
CT scan of would have been obtained prior to image guided drain placement. Any subsequent CT scans up to 1 month follow up upon discharge will be reviewed to assess changes in size of the abscess. This will be monitored for assessing the effectiveness of intervention.
Time frame: From the drain placement up to 1 month follow up
Drain will have certain output that is recorded daily. Daily drain output will be in unit of ml and will be monitored as a measurement of abscess resolution.
Time frame: From the drain placement until 1 month follow up
The total duration of the drain placement will be recorded in days starting from the day of placement up to drain removal and monitored as a effectiveness of the intervention.
Contact information is provided by the study sponsor or research team.
Linda Ahrens
CONTACT
Thomas Granchi, MD
CONTACT
Paolo Goffredo
Other
Acronym: AID
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06906029
Abdominal Abscess, Abscess
Birmingham, Alabama, United States
View Trial DetailsNCT05283733
Abdominal Abscess, Abscess
Zagazig, Egypt
View Trial DetailsNCT03681665
Abdominal Abscess, Abscess
Seoul, South Korea
View Trial DetailsNCT00515034
Abdominal Abscess, Abscess
View Trial Details